Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bayer AG (OTC Pink - Current Information:BAYRY)

125.92
Delayed Data
As of Jul 27
 -4.65 / -3.56%
Today’s Change
91.53
Today|||52-Week Range
139.04
+20.75%
Year-to-Date
Bayer (BAYRY) Q2 Earnings Beat, Sales Miss, Cuts Guidance
Jul 27 / Zacks.com - Paid Partner Content
AVEO Pharmaceuticals (AVEO) Q2 Earnings: What's in Store?
Jul 26 / Zacks.com - Paid Partner Content
Bayer Shares Slump After Chemicals Group Lowers Full-Year Guidance
Jul 27 / TheStreet.com - Paid Partner Content
Repros' Proellex Stays on Partial Clinical Hold, Shares Fall
Jul 18 / Zacks.com - Paid Partner Content
Can Regeneron Pharma (REGN) Pull a Surprise in Q2 Earnings?
Jul 26 / Zacks.com - Paid Partner Content
Paratek Antibiotic Candidate's Phase III Data Favorable
Jul 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close130.57
Today’s open127.20
Day’s range125.65 - 127.31
Volume119,411
Average volume (3 months)72,184
Market cap$108.0B
Dividend yield2.35%
Data as of 3:59pm ET, 07/27/2017

Growth & Valuation

Earnings growth (last year)+9.47%
Earnings growth (this year)+11.81%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+0.97%
P/E ratio51.8
Price/Sales1.69
Price/Book3.81

Competitors

No competitors data available.

Financials

Last reporting dateJuly 28, 2017
EPS forecast (this quarter)$2.14
Annual revenue (last year)$51.6B
Annual profit (last year)$5.0B
Net profit margin9.12%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman-
Management Board
Werner Baumann
Chief Financial Officer
Johannes M. Dietsch
Corporate headquarters
Leverkusen, Nordrhein-westfalen

Forecasts